D R Pathak1, J R Osuch, J He. 1. Department of Epidemiology and Family Practice, Michigan State University, East Lansing, Michigan 48823, USA.
Abstract
BACKGROUND: A crossover in breast carcinoma incidence at ages 45-49 years has been observed between black and white women, with blacks experiencing higher incidence at younger ages and lower incidence after age 50 years. Can this phenomenon be partially explained by the differences in the distributions of reproductive risk factors? This article focuses on the effects and distributions of age at first full term pregnancy (FFTP), parity, and oral contraceptive (OC) use in younger versus older and black and white populations. Effects of hormone replacement therapy (HRT) are also summarized. METHODS: A literature review was conducted and information integrated on the effects and distributions of reproductive and hormonal risk factors in black and white populations, the crossover effect of parity, and the Pike model of "breast tissue age." RESULTS: Overall, early age at FFTP and higher parity decreased risk for both races. Distributions of age at FFTP and parity varied widely between the two races. Based on the effects and distributions of age at FFTP and parity, the authors formulated the hypothesis that a crossover in incidence curves between the two races would be expected, rather than be considered an anomaly. Regarding OC use, generally a stronger increase in risk was observed for younger women than for older women. Regarding HRT, a recent meta-analysis observed an increased risk of 1.35 for 5 years of use or more. CONCLUSIONS: To promote public health in diverse populations, and to provide further insight into breast carcinoma etiology, research needs to focus on multicultural differences and similarities in the relation of hormonal risk factors and breast carcinoma. Copyright 2000 American Cancer Society.
BACKGROUND: A crossover in breast carcinoma incidence at ages 45-49 years has been observed between black and white women, with blacks experiencing higher incidence at younger ages and lower incidence after age 50 years. Can this phenomenon be partially explained by the differences in the distributions of reproductive risk factors? This article focuses on the effects and distributions of age at first full term pregnancy (FFTP), parity, and oral contraceptive (OC) use in younger versus older and black and white populations. Effects of hormone replacement therapy (HRT) are also summarized. METHODS: A literature review was conducted and information integrated on the effects and distributions of reproductive and hormonal risk factors in black and white populations, the crossover effect of parity, and the Pike model of "breast tissue age." RESULTS: Overall, early age at FFTP and higher parity decreased risk for both races. Distributions of age at FFTP and parity varied widely between the two races. Based on the effects and distributions of age at FFTP and parity, the authors formulated the hypothesis that a crossover in incidence curves between the two races would be expected, rather than be considered an anomaly. Regarding OC use, generally a stronger increase in risk was observed for younger women than for older women. Regarding HRT, a recent meta-analysis observed an increased risk of 1.35 for 5 years of use or more. CONCLUSIONS: To promote public health in diverse populations, and to provide further insight into breast carcinoma etiology, research needs to focus on multicultural differences and similarities in the relation of hormonal risk factors and breast carcinoma. Copyright 2000 American Cancer Society.
Authors: Christina A Clarke; Theresa H M Keegan; Juan Yang; David J Press; Allison W Kurian; Anish H Patel; James V Lacey Journal: J Natl Cancer Inst Date: 2012-07-05 Impact factor: 13.506
Authors: Shahin Sayed; Zahir Moloo; Ronald Wasike; Peter Bird; Raymond Oigara; Faith Wambui Njoroge; Asim Jamal Shaikh; Satya Vara Prasad; Sudhir Vinayak; Gretchen L Gierach; Sanford M Dawsey; Maya Palakal; Shaoqi Fan; Maeve Mullooly; Rajendra Chauhan; Patricia Okiro; Samuel Gakinya; Ancent Nzioka; Catherine Kyobutungi; Shukri Mohamed; Tilahun Haregu; Mustafa Mussajee; Betty Bonass; Costa Mariwa; Omar Ali Sherman; Abdihakim Mohammed; Andrew Gachii; Joseph Githaiga; Joseph Karanu; Robert Nyagah; Richard Njoroge; Irene Muramba; James Obondi Otieno; Dan Omondi Raburu; Elizabeth B Mwachiro; Innocent Abayo; Mansoor Saleh Journal: Breast Cancer Res Treat Date: 2017-09-26 Impact factor: 4.872
Authors: Annekatrin Lukanova; Helja-Marja Surcel; Eva Lundin; Marjo Kaasila; Hans-Ake Lakso; Helena Schock; Anika Husing; Rudolf Kaaks; Pentti Koskela; Kjell Grankvist; Eero Pukkala; Anne Zeleniuch-Jacquotte; Matti Lehtinen; Paolo Toniolo Journal: Int J Cancer Date: 2011-05-09 Impact factor: 7.396
Authors: Claudia R Baquet; Shiraz I Mishra; Patricia Commiskey; Gary L Ellison; Mary DeShields Journal: J Natl Med Assoc Date: 2008-05 Impact factor: 1.798